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The recent reduction in the efficacy of azole fungicides in control-





, has prompted concerns over possible development
of resistance, particularly in light of the recent emergence of
widespread resistance to quinone outside inhibitors (QoIs). We





-demethylase protein (CYP51), and over-expression of genes
encoding efflux pumps, in reducing sensitivity to the azole class





we report on the prevalence and selection of two CYP51 altera-














tion has previously been identified in human or plant pathogenic









 values across isolates with either
I381 or V381, and had no measurable effect on azole sensitivity.




 show for the first time that a particular CYP51
alteration is differentially selected by different azoles in field
populations of a plant pathogen. Substitution I381V although
not an absolute requirement for reduced azole sensitivity, is
selected by tebuconazole and difenoconazole treatment, sug-
gesting an adaptive advantage in the presence of these two
compounds. Prochloraz treatments appeared to select nega-
tively for I381V, whereas other azole treatments did not or only
weakly impacted on the prevalence of this substitution. These
findings suggest treatments with different members of the















), is the most important





causing estimated annual yield losses of £30 million. Current
commercial wheat cultivars are susceptible or only partially
resistant to the disease in the UK. Since the late 1970s control has
depended mainly on the programmed application of fungicides.
The most active control agents are target site-specific systemic
fungicides, which include the methyl benzimidazole carbamates
(MBCs), sterol demethylation inhibitors (DMIs) and quinone out-
side inhibitors (QoIs). However, resistance to these fungicide




. In the mid 1980s, resist-





-tubulin gene resulting in substitution of a glutamic
acid for an alanine residue at codon 198 (E198A), emerged and




 populations today (B. A.








 populations, also caused by a mutation in the target
gene [replacing an alanine for glycine at position 143 (G143A) of




], was first detected in the UK in
2002 and has since compromised disease control despite meas-









 populations, although recent studies
have demonstrated an erosion of efficacy and higher doses are





2004). Together, these studies have prompted concerns that fur-
ther shifts in azole sensitivity might compromise disease control.





-demethylase (CYP51), an essential enzyme in the biosyn-
thetic pathway of ergosterol, the predominant sterol in plasma
membranes of most fungi. However, unlike most site-specific
fungicides, where a single mutation can confer a highly resistant
phenotype, azole resistance often emerges as a result of multiple
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target site, and fungicide uptake and efflux have all been identi-
fied as resistance mechanisms (Joseph-Horne and Hollomon,




, which can cause serious clinical problems in
immunocompromised patients, strains highly resistant to azoles




 gene and also
over-express efflux pumps of the ATP-binding cassette (ABC) or





























four mutations (Y132H, S405F, G464S and R467K) that affect
azole sensitivity both as single mutations, and to a greater extent









 mutations as well as different mechansims can
combine to confer a step-wise increase in resistance.
Understanding of the mechanisms underlying altered azole
sensitivity in plant pathogens is more limited, primarily as resist-
ance has developed relatively slowly without to date affecting
practical disease control. The amino acid substitution Y136F,




, has been associated




























 using crosses between azole-sensitive and
azole-resistant isolates demonstrated resistance-linked segrega-
tion of CYP51 substitutions, Y136F and K147Q, although it was
also suggested that these mutations were not the sole determi-
nants of the resistant phenotype (Wyand and Brown, 2005).




spp. but their exact contribution to azole insensitivity has yet to





























 mutations were not
identified, but alternative mechanisms, including over-expression
of the target gene, correlated with reduced azole sensitivity.













obtained in the mid 1990s, reduced azole sensitivity was associ-









 mutations reported. However,
several CYP51 alterations were recently identified in field isolates
with reduced sensitivity to azoles, along with up-regulation of










associated with azole resistance, whereas combinations of alter-
ations [e.g. I381V, Y459D, Y461H and a 6-bp deletion covering














reported high levels of azole resistance and high frequencies of




populations sampled in Switzerland, Germany and England and
suggested that this was due to intensive use of azoles on cereals
in this part of Europe.
The objective of this study was to determine the incidence,
prevalence and selection by different azoles of CYP51 alterations














allele as a comparison. Data obtained from fungicide sensitivity
assays and quantitative allele-specific PCR measuring the fre-
quency of I381V show for the first time in a population of a fungal
pathogen that a specific change in the CYP51 target site protein



















 populations sampled at Rothamsted Research in
2003, 2004, 2005 and 2006 were distinct between azoxystrobin,
epoxiconazole and tebuconazole (Fig. 1). In 2003, isolates fell





 < 0.2 mg/L and > 0.9 mg/L, forming a bimodal
distribution commonly associated with single gene-mediated
resistance. In comparison with 2003, where 40% of the isolates




 values > 0.9 mg/L, the resist-
ant subpopulation was further selected in subsequent years,
culminating in a population containing 96% of highly resistant





 isolates in the Rothamsted popu-
lations was more continuous within years (Fig. 1B,C). A shift in
sensitivity to epoxiconazole occurred between 2003 and 2004




 value increasing from 0.13 to 0.22 mg/L.










 increased from 0.28 mg/L in 2004 to 0.52 mg/L in









 distribution pattern of tebuconazole was similar to that
for epoxiconazole. There was a clear shift in sensitivity to tebuconazole





increasing from 0.85 to 2.95 mg/L and 1.11 to 2.73 mg/L, respectively.





ured in 2005 (2.58 and 2.67 mg/L) and 2006 (3.12 and 3.02 mg/L).
 
Detection of CYP51 I381V and ∆
 
Y459/G460 alterations 
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of a third Cy5-labelled probe in the assay, St381uni (Table 1),
facilitated determination of fluorescent signal ratios and
subsequent calculation of I381V frequencies in population





Y459/G460 was not specific enough due to cross-
reactivity (Fig. 2C,D), making determination of frequencies of
this deletion in population samples impossible. The assay could,




Y459/G460. With regard to MGB probe specificity, no differ-




isolates carrying substitutions Y459D, G460D or Y461H and
isolates carrying wild-type CYP51 (Y459/G460/Y461) (data not
shown).
 
Relationship between isolate azoxystrobin, 
epoxiconazole and tebuconazole sensitivity and 
cytochrome b substitution G143A
 





in the 2003, 2004, 2005 and 2006 Rothamsted population was
plotted against isolate sensitivity to azoxystrobin, epoxiconazole
and tebuconazole (Fig. 3A–C, respectively). All isolates with




 values > 0.9 mg/L whereas




 values < 0.2 mg/L
(Fig. 3A). No clear relationship between the presence of G143A
and sensitivity to epoxiconazole and tebuconazole was apparent,




 values across isolates with




values for both epoxiconazole and tebuconazole carried A143
alleles, but this might be due to the fact that isolates carrying
G143 alleles have become rare in the populations sampled after
2003. In 2006, 96% of the isolates tested carried A143 alleles
(Table 2).
 
Relationship between isolate azoxystrobin, 
epoxiconazole and tebuconazole sensitivity and 




The frequency of isolates carrying the I381V substitution
increased between 2003 and 2004, with frequencies of 40 and
60%, respectively, stabilizing in 2005 and 2006 (Table 2). Inter-
estingly, a high proportion of isolates (between 89 and 94%) car-





Y459/G460 was much lower, between 15 and 29%,
with no clear selection of this alteration over time being evident
(Table 2). Figure 4 shows the association between different










 values for azoxystrobin and epoxiconazole (Fig. 4A,B).
Isolates with I381V followed the same trend, but, interestingly,




Y459/G460 were also carrying





ues > 0.9 mg/L. Generally, the majority of I381 isolates, 48 out of
75 isolates tested, were more sensitive to tebuconazole than
Fig. 1 Sensitivity of M. graminicola isolates to azoxystrobin (A), epoxiconazole 
(B) and tebuconazole (C) at Rothamsted between 2003 and 2006. Isolates 
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the mutant V381 isolates, where only five out of 107 isolates
tested had tebuconazole EC50 values < 1.0 mg/L (Fig. 4C).
∆Y459/G460 was continuously distributed across isolate EC50
values irrespective of I381V and therefore had no effect on
tebuconazole sensitivity.
Prevalence of I381V in untreated and fungicide-treated 
leaf populations sampled during 2001–06
The frequency of I381V measured in population samples
increased from 20.6% in 2001 to 56.7% in 2006 (Table 3). These
Fig. 2 Allele-specific PCR signals generated from M. graminicola isolates carrying exclusively CYP51 I381 (A), V381 (B), Y459/G460 (C) and ∆Y459/G460 (D) 
alterations. Solid and open squares represent levels of FAM and VIC fluorescence, respectively.
Table 1 Overview of oligonucleotides used in this study.
Oligonucleotide name Type* Oligonucleotide Sequence and labelling (5′−3′)† (µM) Concentration Target (allele)
Stbf1 Forward primer ACATTAACATGAACAATCGGTACTATAATACTAG 0.5 Cytochrome b
Stbr1 Reverse primer GGATTTCCTGAACCCGCTG 0.3 Cytochrome b
Stcbuni Probe Cy5-AATGCAGCTAACACAAACGGTAAAACGA-BHQ-2 0.1 Cytochrome b
Stcbwt MGB probe FAM-CTGTTGCTCCTCATAA 0.1 Cytochrome b (G143)
Stcbmt MGB probe VIC-TTGCTGCTCATAAAG 0.1 Cytochrome b (A143)
St381f Forward primer GCCAACCTCTCGAAACTCAC 0.4 CYP51
St381r Reverse primer TGGGTGGTTGGAATGACGTA 0.4 CYP51
St381uni Probe Cy5-CTCCTCAATCAAGTCGTCAAAGAAACCCTTC-BHQ-2 0.2 CYP51
St381wt MGB probe VIC-AATGGAGTGGATTGGA 0.25 CYP51 (I381)
St381mt MGB probe FAM-AATGGAGTGGACTGGA 0.075 CYP51 (V381)
Stcpf1 Forward primer GACGACTGCCCTAGGAAGCAT 0.5 CYP51
Stcpr1 Reverse primer CGCGCCCTTGCTTACAA 0.5 CYP51
Stcpwt MGB probe FAM-CATAGTCTTCTTTCTCC 0.06 CYP51 (Y459/G460)
Stcpdel MGB probe VIC-CCGTAGTCTTCTTTCT 0.2 CYP51 (∆Y459/G460)
*MGB, Minor Groove Binder probe (see Afonina et al., 1997).
†FAM (6-carboxy-fluorescein), VIC and Cy5 are fluorescent labels; BHQ-2 is a dark Black Hole Quencher.
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results corresponded well with the values obtained for testing of
isolates derived from the same samples (Table 2). The largest
increase in I381V frequency was measured between 2003
(27.7%) and 2004 (48.1%). Selection was evident after tebuco-
nazole treatment with I381V frequencies increasing from 20.6
to 62.8% and 25.2 to 86.8% in 2001 and 2002, respectively.
Decreased sensitivity for tebuconazole in the presence of I381V
agreed well with the results obtained in isolate EC50 testing
where 95% of isolates carrying this substitution had values
≥ 1.0 mg/L (Fig. 4C). No increase in I381V frequency was
measured for fluquinconazole-treated populations, and frequen-
cies were only slightly raised in populations exposed to epoxico-
nazole in 2001 (23.7%) and 2002 (36.9%).
In 2006, M. graminicola populations were exposed to 12
different DMI fungicides at three different locations (Fig. 5). For
all three locations a similar pattern of selection for I381V was
observed. The selection was clearest in the Somerset population
(Fig. 5A) where the lowest I381V frequency between locations
(63%) was measured in untreated plots. I381V frequencies in
untreated populations sampled in Herefordshire (Fig. 5B) and
Norfolk (Fig. 5C) were 75 and 82%, respectively, Both positive
and negative selection for I381V was observed in treated popu-
lations. For all locations, clear positive selection for I381V was
measured in populations treated with the triazoles difenocona-
zole and tebuconazole, resulting in allele frequencies > 90%. A
weaker positive selection was observed for metconazole and
tetraconazole. Negative selection for I381V in the populations
sampled was most prominent and consistent after application of
the imidazole prochloraz. In comparison with untreated plots, the
largest decrease in I381V frequency was measured in Somerset,
with frequencies of 63 and 34% in untreated and prochloraz
treated plots, respectively.
Relationship between isolate prochloraz sensitivity 
and I381V
The negative selection for substitution I381V in M. graminicola
populations upon treatment with prochloraz observed in the
2006 field trials was further examined using isolate EC50 testing.
Fig. 3 Distribution of the cytochrome b G143A across EC50 values of 
M. graminicola isolates in Rothamsted populations to azoxystrobin (A), 
epoxiconazole (B) and tebuconazole (C). Genotypes 1 and 2 represent, 
respectively, G143 and A143 alleles.
Table 2 Prevalence of different cytochrome b and CYP51 alterations in M. graminicola populations sampled at Rothamsted.
Population*










2003 (n = 40) 16 16 6 12 3 3 3
2004 (n = 45) 27 36 13 26 6 10 6
2005 (n = 43) 28 39 5 25 3 5 3
2006 (n = 54) 36 52 10 34 8 10 8
*Populations with the number of isolates (n) tested in parentheses.
†Isolate alterations (cytochrome b G143A and CYP51 I381V and ∆459/460) were detected with allele-specific real-time PCR.
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Figure 6 shows the results for Rothamsted 2006 isolates (n = 54).
As expected, most of the isolates carrying I381V were more sen-
sitive to prochloraz, with 25 out of 36 isolates having EC50 values
≤ 0.1 mg/L. This is in sharp contrast to isolates not carrying this
alteration, with 17 out of 18 showing an EC50 > 0.1 mg/L. ∆Y459/
G460 again showed a continuous distribution of EC50 values
across isolates irrespective of I381V, and therefore had no obvi-
ous effect on prochloraz sensitivity (data not shown).
DISCUSSION
Analysis of the sensitivities of M. graminicola isolates in Rotham-
sted populations in 2003–06 revealed the expected disruptive
selection towards a QoI-resistant population conferred by the
predominance of a single mutation encoding substitution,
G143A. By contrast, over the last 4 years, changes in the popula-
tion towards decreased sensitivity to the azoles have been
continuous, with new phenotypes (EC50 groupings) gradually
emerging. This phenomenon is common when reduced sensitivity
is mediated by several genes and/or mutations each contributing
discretely to the final phenotype (Brent and Hollomon, 1998).
Interestingly, between 2003 and 2004, a relatively large shift in
median EC50 was measured for both epoxiconazole and tebuco-
nazole (Fig. 1). A possible explanation is a hitch-hiking effect of
QoI resistance selection. During this period a large proportion of
the population carrying G143A was selected, with frequencies
increasing from 40 to 80% (Table 2). It is plausible that a rela-
tively large proportion of this subpopulation also carried the
I381V substitution (see Fig. 4C).
I381V does not or only weakly confers reduced sensitivity to
epoxiconazole, as EC50 distribution patterns for isolates carrying
this substitution were similar to wild-type isolates (Fig. 4B). By
contrast, a clear relationship between the presence of I381V and
reduced tebuconazole sensitivity is apparent (Fig. 4C). Most iso-
lates with I381V are less sensitive (EC50 ≥ 1.0 mg/L), although
other mechanisms undoubtedly also contribute to reduced tebu-
conazole sensitivity, as a few isolates without this alteration also
have high EC50 values. The presence of ∆Y459/G460 did not seem
to have a direct impact on the azole sensitivity of isolates.
Population studies confirmed the results of fungicide sensitivity
tests. In comparison with untreated populations, increased
mutation frequencies show that isolates carrying I381V were
Fig. 4 Distribution of the I381V and ∆Y459/G460 CYP51 alterations across 
EC50 values of M. graminicola isolates in Rothamsted populations to 
azoxystrobin (A), epoxiconazole (B) and tebuconazole (C). Genotype 1 
represents presence of I381, genotype 2: I381 and ∆Y459/G460, genotype 3: 
V381 and genotype 4: V381 and ∆Y459/G460 CYP51 alterations, respectively.
Table 3 Frequency of I381V in azole-treated and untreated M. graminicola 
populations sampled at Rothamsted.
Cultivar Year Treatment I381V frequency*
Riband 2001 Untreated 20.6 ± 0.3
Riband 2001 Epoxiconazole 23.7 ± 0.4
Riband 2001 Fluquinconazole 17.3 ± 3.9
Riband 2001 Tebuconazole 62.8 ± 0.8
Savannah 2002 Untreated 25.2 ± 0.1
Savannah 2002 Epoxiconazole 36.9 ± 1.0
Savannah 2002 Fluquinconazole 21.0 ± 0.1
Savannah 2002 Tebuconazole 86.8 ± 1.8
Savannah 2003 Untreated 27.7 ± 0.5
Hereward 2004 Untreated 48.1 ± 4.6
Consort 2005 Untreated 54.5 ± 2.0
Robigus 2006 Untreated 56.7 ± 5.8
*Frequency, mean of two measurements ± SE, was determined in 
allele-specific real-time PCR.
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selected in populations exposed to tebuconazole in all trials con-
ducted during 2001–06 (Table 3 and Fig. 5). Results from the
2006 trial showed a clear difference in selection pressure for
I381V for 12 azoles currently marketed in the UK. Strong selec-
tion for I381V was observed after application of tebuconazole,
difenoconazole and, to a lesser extent, metconazole. For most
other azoles, selection for I381V was either weak (e.g. epoxico-
nazole and tetraconazole) or absent (e.g. flutriafol and flusilazole).
Interestingly, negative selection for this substitution was
observed in populations treated with prochloraz.
Selection can be affected by differences in the intrinsic activity
of azoles; however, Clark (2006) has shown, by comparing cur-
rent and past field performance in the UK, that the azoles used
in this trial were not affected to the same degree by resistance
development. Differential selection of I381V between azoles may
result from differences in side chain chemistry. Although selection
of CYP51 alterations by azoles of varying side chain chemistries
has not previously been reported, differences in the activity of
azole derivatives against fungi of varying CYP51 secondary struc-
ture have been. For example, differences in the intrinsic activity
of fluconazole against C. albicans and C. krusei (Fukuoka et al.,
2003) are thought to result from CYP51 variation. Furthermore,
divergent side chain structure is suggested to be responsible for
the efficacy of ketoconazole and itraconazole against flucona-
zole-resistant C. albicans strains carrying substitution Y132H
(Sanglard et al., 1998). Therefore, as the residue equivalent to
I381 in the crystal M. tuberculosis CYP51 protein, L321, is not
only predicted to form a substrate recognition site, but also lies
within 4 Å of the heme-bound azole ligand (Podust et al., 2001),
it seems reasonable to suggest interaction of this residue with the
azole side chain.
The discovery that I381V correlates with a clear reduction in
tebuconazole sensitivity and increased sensitivity to prochloraz
may have implications for the use of these compounds in control-
ling M. graminicola populations as part of an anti-resistance
strategy. However, in previous studies (Cools et al., 2005a; Ster-
giopoulos et al., 2003), a number of mechanisms, including over-
expression of efflux pumps and multiple CYP51 amino acid
changes, were proposed to confer decreased sensitivity to azoles.
In view of the finding that I381V is not solely required for reduced
tebuconazole sensitivity, let alone for reduced sensitivity to other
azoles, monitoring of this substitution, although useful, is not a
sufficiently robust diagnostic tool to predict potential control
Fig. 5 Selection of I381V in untreated and azole-treated populations of 
M. graminicola sampled in Somerset (A), Herefordshire (B) and Norfolk (C).
Fig. 6 Distribution of the CYP51 I381V substitution across prochloraz EC50 
values of M. graminicola strains isolated in 2006. Genotypes 1 and 2 represent, 
respectively, I381 (wild-type) and V381 CYP51 variants.
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problems. Therefore, further functional studies are underway to deter-
mine not only the precise impact of I381V and other CYP51 alterations
(e.g. alterations in codon region 459–461) on M. graminicola
azole sensitivity but also their effect on intrinsic protein activity,
and therefore fitness of isolates carrying these alterations.
EXPERIMENTAL PROCEDURES
Fungal isolates
Strains of M. graminicola were isolated from untreated fields at
Rothamsted at the start of the season during 2003–06. The
cultivars grown were Savannah (2003), Hereward (2004), Con-
sort (2005) and Robigus (2006). Strains were derived from
individual leaves sampled randomly with at least 5 m distance
between each sampling point. Isolations of M. graminicola from
plants were made according to Duncan and Howard (2000). Leaf
pieces with lesions were placed on to sterile moist filter paper in
up-turned Petri dishes and incubated at 23 °C overnight. Cirri,
emerging from pycnidia, were collected using sterile forceps
under a dissecting microscope and transferred into 0.5-mL sterile
microfuge tubes containing 30 µL of sterile distilled water. Conid-
ial suspensions were streaked on to antibiotic-amended yeast
potato dextrose agar (YPD; ForMedium, Norwich, UK) amended
with penicillin G sodium and streptomycin sulphate at 100 µg/
mL, and incubated for 5 days at 23 °C. Single colonies subse-
quently grew in the form of yeast-like budding cells. Single spore
isolates were propagated by transferring single colonies to fresh
YPD plates. Isolates were either used directly in sensitivity assays
or stored in 80% glycerol at −80 °C.
Fungicide sensitivity assays
Sensitivity assays were carried out according to Pijls et al. (1994)
with the following modifications. Wells of flat-bottomed microti-
tre plates (TPP 92696 test plates, Trasadingen, Switzerland) were
filled with 100 µL of liquid Czapek dox medium (Oxoid, Basing-
stoke, UK) amended with 60, 20, 6.7, 2.2, 0.74, 0.25, 0.08, 0.027,
0.009, 0.003 or 0.001 µg/mL of epoxiconazole, tebuconazole,
prochloraz and azoxystrobin. Aliquots of 100 µL of spore suspen-
sions (105 conidia/mL) of each M. graminicola isolate were added
to each well. Plates were incubated for 4 days at 23 °C, and
growth measured in an MRX plate reader (Dynex Technologies,
Chantilly, VA) at 630 nm. Fungicide sensitivities were determined
as 50% effective concentration (EC50) values calculated using a
dose–response relationship.
DNA extraction and quantification
DNA was extracted from conidia and infected leaves as described
previously by Fraaije et al. (1999). For extraction of DNA from
plant samples containing more then ten leaves, a roller press
(Pollähne, Wennigsen, Germany) was used as described by Rohel
et al. (2002). DNA was quantified in flat-bottomed polystyrene
96-well microtitre plates using the fluorescent dye Thiazole
Orange (2.5 µM) (Aldrich Chemical Co., Milwaukee, WI). Fluores-
cence was measured at 530 nm with excitation at 485 nm using
an FLx800 fluorimeter (Bio-Tek Instruments Inc., Winooski, VT).
For testing leaf samples using real-time PCR, 50 ng of ‘total’ (mix
of plant and microbes) DNA was tested.
Allele-specific real-time PCR
To quantify pathogen target DNA and measure the frequency of
QoI-resistant (A143) alleles in a single reaction, a previously
developed PCR assay was used in which two primers and three
probes act simultaneously (Fraaije et al., 2005b). The primer and
probe sequences for this assay are presented in Table 1. For quan-
titative detection of substitution I381V and ∆Y459/G460 a similar
approach was sought. Primers and probes (Table 1) based on
TaqMan chemistry were designed with Primer Express Software
(Version 7.1, Applied Biosystems, Foster City, CA) using the pub-
lished CYP51 sequence (GenBank accession no. AF263470) as
template. The probe design to detect ∆Y459/G460 was difficult
due to sequence limitations, and therefore final probe sequences
were provided through the Applied Biosystems Assays-by-Design
Service, with primers designed using Primer Express Software
(Table 1). The specificity of all primers and probes used in this
study was further checked by BLAST nucleotide database
searches and by testing against genomic DNA of wheat and
several other cereal pathogens.
For all assays, PCR reactions were performed in 20-µL reaction
volumes (capped Thermo-Fast 96 PCR Plates; ABgene, Epsom,
UK), consisting of 2.5 µL DNA sample, 10.0 µL Platinum® Quan-
titative PCR SuperMix-UDG (Invitrogen Life Sciences, Carlsbad,
CA) and 7.5 µL sterile distilled water containing primers, probes
and ROX reference dye (Invitrogen; 0.04 µL per reaction). The
final concentrations of the primers and probes in each assay are
presented in Table 1. Reactions were carried out in an Mx3000P
Real Time PCR System (Stratagene Europe, Amsterdam, The Neth-
erlands) for 2 min at 50 °C, 2 min at 95 °C, followed by 50 cycles
of 15 s at 95 °C and 1 min at 60 °C. The increase in fluorescence
from probes was measured at every temperature step and cycle
during the reaction. For each sample in the cytochrome b G143A
and CYP51 I381V assay, the threshold cycle (Ct, cycle at which
the increase of fluorescence exceeded the background) for the
Cy5-labelled probe was determined. Cleavage of this probe is
correlated with the amount of total pathogen DNA as it binds
independently of either cyt b or CYP51 mutations. For each sam-
ple, the ratio of the mutant and wild-type genotypes, as meas-
ured by release of FAM and VIC fluorescence upon cleavage of the
matching sequence, was measured five cycles after detection
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with the Cy5-labelled probe. Standard curves were generated by
plotting known mutant genotype frequencies against signal
ratios. Resulting regression equations were used to determine
mutation frequencies in ‘unknown’ samples. Standards for meas-
urement of mutation frequencies were included in each PCR run.
Field trials and population survey samples
For population samples, 25 leaves with symptoms were pooled.
As well as sampling of untreated fields at Rothamsted during
2003–06, additional samples were available from previous
experiments conducted at Rothamsted during 2001 (cv. Riband)
and 2002 (cv. Savannah), in which single plots of 10 × 3 m were
left untreated or treated with three sprays of epoxiconazole
(83 g/ha), fluquinconazole (83 g/ha), tebuconazole (167 g/ha)
and trifloxystrobin (167 g/ha) (see Fraaije et al., 2005a). Addi-
tional samples were received from field trials carried out by ADAS
with cv. Consort in Taunton (Somerset, UK), Felton (Herefordshire,
UK) and Terrington St. Clement (Norfolk, UK) (see Clark, 2006). A
randomized block design, incorporating 12 treatments with four
replicate plots of 24 × 2 m, was used. Plots were left untreated
or sprayed twice with cyproconazole (80 g/ha), difenoconazole
(75 g/ha), epoxiconazole (125 g/ha), flusilazole (125 g/ha), flutri-
afol (125 g/ha), fluquinconazole (125 g/ha), metconazole (90 g/
ha), prochloraz (405 g/ha), propiconazole (125 g/ha), prothioco-
nazole (200 g/ha), tebuconazole (250 g/ha) and tetraconazole
(125 g/ha) at GS 32 and 39. At least ten leaves of leaf 2 (leaf
below flag) of each plot was sampled at random 3 weeks after
the final spray and leaves of replicate plots were pooled together
to obtain a population sample.
Statistical analysis
The significance of the effects of the different fungicide treat-
ments on the frequency of I381V in populations was determined
by ANOVA analysis using Genstat, 8th edition (VSN International
Ltd, Hemel Hempstead, UK).
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